OSR Health (OSRHW) EBIT (2022 - 2026)

OSR Health has reported EBIT for 5 years, with the latest figure at -$3.7 million in Q1 2026.

• Quarterly EBIT fell 25.68% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.1 million (down 68.82% YoY) and the FY2025 annual result came in at -$18.3 million, down 56.85% from the prior year.
• EBIT rose to -$3.7 million in Q1 2026 per OSRHW's latest filing, from -$6.4 million in the prior quarter.
• Over five years, EBIT peaked at $530029.0 in Q2 2023 and troughed at -$6.4 million in Q4 2025.
• A 5-year average of -$2.0 million and a median of -$2.3 million in 2024 frame the typical range for EBIT.
• The sharpest annual moves came in 2023 and 2024: EBIT surged 53746.66% in 2023, then slumped 2465.27% in 2024.
• Over 5 years, EBIT stood at -$14252.0 in 2022, then jumped by 3064.09% to $422442.0 in 2023, then sank by 481.31% to -$1.6 million in 2024, then slumped by 296.41% to -$6.4 million in 2025, then surged by 42.57% to -$3.7 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$3.7 million, -$6.4 million, and -$3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.